tirzepatide supplier Research Peptide | GIP GLP-1 Research Tirzepatide 60mg Lyophilized Peptide Vial

In the US, cash-paying patients have a 12-month persistence rate of 13%, while insured individuals see rates of 36%4

The massive popularity of GLP-1 weight loss drugs is yielding huge donations to Christian causes, thanks to the substant

18% of US adults have tried a GLP-1 drug to lose weight or to treat diabetes or heart disease, and 12% are currently using them, per new KFF survey data

Eat less, move more is not a long-term weight management solution

The findings suggest that providers are largely following recommended dosing schedules designed to improve tolerability as oral GLP-1 therapies continue to gain traction in obesity treatment

Click here for a comparison of Tesofensine vs Semaglutide to find out which medication is right for you.